Download PDF
Ernährung & Medizin 2010; 25: 3-18
DOI: 10.1055/s-0030-1248842
Wissen
© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Praktische Aspekte bei der Zufuhr von Omega-3-Fettsäuren

Peter Singer
Further Information

Publication History

Publication Date:
18 March 2010 (online)

    Permissions and Reprints

Zusammenfassung

In Deutschland besteht ein Defizit an Omega-3-Fettsäuren. Das gilt für alle Altersgruppen. Vegetarier haben besonders geringe Konzentrationen von langkettigen Omega-3-Fettsäuren in ihren Blutfetten. Die meisten internationalen Gremien empfehlen eine Zufuhr von mehr als 300 mg/Tag in der Primärprävention und 1000 mg/Tag in der Sekundärprävention (nach Herzinfarkten). Detaillierte Kenntnisse über die einzelnen Nahrungsquellen erleichtern die Auswahl, möglichst in Form eines Mischkonzepts. Die Zufuhr sollte kontinuierlich, eigentlich lebenslang, unter Beachtung der verschiedenen Indikationen der einzelnen Omega-3-Fettsäuren erfolgen.

Schlüsselwörter

Omega-3-Fettsäuren - Seefisch - Fischöl - Pflanzenöle - funktionelle Lebensmittel - Nahrungsergänzungsmittel - Arzneimittel - Empfehlungen

Literatur

  • 1 Adam O. Fischölfettsäuren als Therapeutika.  Med Klinik. 1990;  85 92-96
    PubMedGoogle Scholar
  • 2 Bahri D, Gusko M, Hamm M et al.. Bedeutung und empfehlenswerte Höhe der Zufuhr langkettiger Omega-3-Fettsäuren – Ein Konsensus-Statement des Arbeitskreises Omega-3.  Ernährungs-Umschau. 2002;  49 94-98
    PubMedGoogle Scholar
  • 3 Bauch A, Lindtner O, Mensink G BM et al.. Dietary intake and sources of long-chain n-3 PUFA in German adults.  Eur J Clin Nutr. 2006;  61 1-3
    PubMedGoogle Scholar
  • 4 Bjerregaard P, Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland.  Int J Epidemiol. 1988;  17 514-519
    CrossrefPubMedGoogle Scholar
  • 5 Bjerve K S. N-3 fatty acid deficiency in man.  J Intern Med. 1989;  225 (S 01) 171-175
    PubMedGoogle Scholar
  • 6 de Lorgeril M, Salen P, Martin J L et al.. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study.  Circulation. 1999;  99 779-785
    CrossrefPubMedGoogle Scholar
  • 7 Deutsche Gesellschaft für Ernährung e. V. (DGE) et al.. Referenzwerte für die Nährstoffzufuhr. Neustadt/Weinstr: Neuer Umschau; 2008
    PubMedGoogle Scholar
  • 8 EFSA . Scientific opinion of the panel on dietetic products, nutrition and allergies on a request from the European Commission related to labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids.  The EFSA Journal. 2009;  1176 1-11
    PubMedGoogle Scholar
  • 9 Eurodiet .Nutrition & Diet for Healthy Lifestyle in Europe. http://http://eurodiet.med.uoc.gr/ [accessed 17 April 2006]
    PubMedGoogle Scholar
  • 10 Fisch-Informationszentrum .Fischwirtschaft – Daten und Fakten 2009. http://www.fischinfo.de [Stand: 06.01.2010]
    PubMedGoogle Scholar
  • 11 Foran J A, Good D H, Carpenter D O. Quantitative analysis of the benefit of consuming farmed and wild salmon.  J Nutr. 2005;  135 2639-2643
    PubMedGoogle Scholar
  • 12 Gerster H. Can adults adequately convert alpha-linolenic acid (18 : 3, n-3) to eicosapentaenoic acid (20 : 5, n-3) and docosahexaenoic acid (22 : 6, n-3)?.  Int J Vitamin Nutr Res. 1998;  68 159-173
    PubMedGoogle Scholar
  • 13 GISSI-Prevenzione Investigators . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial.  Lancet. 1999;  354 447-455
    CrossrefPubMedGoogle Scholar
  • 14 Hamm M, Neuberger D. Omega-3 aktiv – Gesundheit aus dem Meer. Hannover: Schlütersche Verlagsanstalt; 2008
    Google Scholar
  • 15 Harris W S. The omega-6/omega-3 ratio and cardiovascular risk: Uses and abuses.  Curr Atheroscler Rep. 2006;  8 453-459
    CrossrefPubMedGoogle Scholar
  • 16 Harris W S, Mozaffarian D, Lefevre M et al.. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids.  J Nutr. 2009;  139 804S-819S
    CrossrefPubMedGoogle Scholar
  • 17 Horrobin D F. Loss of delta-6-desaturase activity as a key factor in aging.  Med Hypotheses. 1981;  7 1211-1220
    CrossrefPubMedGoogle Scholar
  • 18 International Society for the Study of Fatty Acids and Lipids (ISSFAL) .Recommendations for intake of polyunsaturated fatty acids in healthy adults (Statement 3 PUFA in Adults). 2004 http://www.issfal.org.uk [Stand: 6.1.2010]
    PubMedGoogle Scholar
  • 19 Joint WHO/FAO Expert Consultation . Diet, nutrition, and the prevention of chronic diseases.  WHO Technical Report Series. 2003;  No. 916 89-90
    PubMedGoogle Scholar
  • 20 Koletzko B, Lien E, Agostoni C World Association of Perinatal Medicine Dietary Guidelines Working Group et al;. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations.  J Perinat Med. 2008;  36 5-14
    CrossrefPubMedGoogle Scholar
  • 21 Kris-Etherton P M, Taylor D S, Yu-Poth S et al.. Polyunsaturated fatty acids in the food chain in the United States.  Am J Clin Nutr. 2000;  71 (Suppl.) 179S-188S
    PubMedGoogle Scholar
  • 22 Kris-Etherton P M, Harris W S, Appel l J. Fish consumption, fish oil, omega-3-fatty acids, and cardiovascular disease.  Circulation. 2002;  106 2747-2757
    CrossrefPubMedGoogle Scholar
  • 23 Linseisen J, Schulze M B, Saadatian-Elahi M et al.. Quantity and quality of dietary fat, carbohydrate, and fibre intake in the German EPIC cohorts.  Ann Nutr Metab. 2003;  47 37-46
    CrossrefPubMedGoogle Scholar
  • 24 Malasanos T H, Stacpoole P W. Biological effects of omega-3 fatty acids in diabetes mellitus.  Diabetes Care. 1991;  14 1160-1179
    CrossrefPubMedGoogle Scholar
  • 25 Mozaffarian D, Lemaitre R N, Kuller L H et al.. Cardiac benefits of fish consumption may depend on the type of fish meal consumed.  Circulation. 2003;  107 1372-1377
    CrossrefPubMedGoogle Scholar
  • 26 Multiple Risk Factor Trial Research Group . Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a prior hypothesis of the trial.  JAMA. 1990;  263 1795-1801
    CrossrefPubMedGoogle Scholar
  • 27 Max Rubner-Institut – Bundesforschungsinstitut für Ernährung und Lebensmittel Hrsg.. Nationale Verzehrsstudie II, Ergebnisbericht Teil 2. Karlsruhe: Bundesforschungsinstitut f. Ernährung u. Lebensmittel; 2008
    PubMedGoogle Scholar
  • 28 Richter V, Rassoul F, Hamm M. Omega-3-Fettsäuren und kardiovaskuläres Risiko: Konsens trotz weiteren Forschungsbedarfs.  Perfusion. 2008;  21 50-55
    PubMedGoogle Scholar
  • 29 Richter V, Rassoul F, Hentschel B et al.. Age-dependence of lipid parameters in the general population and vegetarians.  Z Gerontol Geriatr. 2004;  37 207-213
    PubMedGoogle Scholar
  • 30 Rosell M S, Lloyd-Wright Z, Appleby P N et al.. Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men.  Am J Clin Nutr. 2005;  82 327-334
    PubMedGoogle Scholar
  • 31 Simopoulos A P. ISSFAL Round Table. The future of fatty acids in human nutrition: Health and policy implications.  ISSFAL Newsletter. 1995;  2 2-3
    PubMedGoogle Scholar
  • 32 Simopoulos A P, Leaf A, Salem N. Essentiality of and recommended dietary intake for omega-6 and omega-3 fatty acids.  Ann Nutr Metab. 1999;  43 127-130
    CrossrefPubMedGoogle Scholar
  • 33 Simopoulos A P. Importance of the ratio of omega-6/omega-3 essential fatty acids: Evolutionary aspects.  World Rev Nutr Diet. 2003;  92 1-22
    PubMedGoogle Scholar
  • 34 Sinclair A J, O’ Dea K, Naughton J M. Elevated levels of arachidonic acid in fish from Northern Australian coastal waters.  Lipids. 1983;  18 877-881
    CrossrefPubMedGoogle Scholar
  • 35 Sinclair H M. Advantages and disadvantages of an Eskimo diet. In: Fumagalli R, Kritchevsky D, Paoletti R Drugs Affecting Lipid Metabolism. Amsterdam: Elsevier; 1980: 363-370
    Google Scholar
  • 36 Singer P. Was sind, wie wirken Omega-3-Fettsäuren? 44 Fragen – 44 Antworten. Frankfurt/M.: Umschau-Zeitschriftenverlag; 2000
    PubMedGoogle Scholar
  • 37 Singer P. Fluvastatin plus fish oil are more effective on cardiovascular risk factors than fluvastatin alone.  Prostaglandins Leukot Essent Fatty Acids. 2005;  72 379-380
    CrossrefPubMedGoogle Scholar
  • 38 Singer P. Kombination von Omega-3-Fettsäuren mit Arzneimitteln und Vitaminen.  Komplement Integr Med. 2007;  8 36-41
    PubMedGoogle Scholar
  • 39 Singer P. Geringer Gehalt von Omega-3-Fettsäuren bei Vegetariern und Veganern.  Komplement Integr Med. 2008;  3 16-23
    PubMedGoogle Scholar
  • 40 Singer P. Die Wirksamkeit von Omega-3-Fettsäuren kann nicht bezweifelt werden!.  J Orthom Med. 2006;  14 109
    PubMedGoogle Scholar
  • 41 Singer P, Berger I, Wirth M et al.. Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentaenoic-acid rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects.  Prostaglandins Leukot Med. 1986;  24 173-193
    CrossrefPubMedGoogle Scholar
  • 42 Singer P, Melzer S, Goschel M et al.. Fish oil amplifies the effect of propranolol in mild essential hypertension.  Hypertension. 1990;  16 682-691
    PubMedGoogle Scholar
  • 43 Singer P, Wirth M, Berger I et al.. Long-chain omega 3 fatty acids are the most effective polyunsaturated fatty acids for dietary prevention and treatment of cardiovascular risk factors.  World Rev Nutr Diet. 1992;  69 74-112
    PubMedGoogle Scholar
  • 44 Singer P, Wirth M. Omega-3 Fettsäuren marinen und pflanzlichen Ursprungs: Versuch einer Bilanz.  Ernährungs-Umschau. 2003;  50 296-304
    PubMedGoogle Scholar
  • 45 Steffen W. Effects of variation in essential fatty acids in fish feeds nutritive value of fresh water fish for humans.  Aquaculture. 1997;  51 97-119
    PubMedGoogle Scholar
  • 46 UK Scientific Advisory Committee on Nutrition .Reports & Position Statements: The effects of long chain polyunsaturated fatty acids on early human growth and cognitive function (3.3.2004). http://http://www.sacn.gov.uk [accessed 6.1.2010]
    PubMedGoogle Scholar

Priv.-Doz. Dr. med. Peter Singer

Fischerinsel 4

10179 Berlin

      >